ArticlePloS one2022

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.

Charlotte Liisborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.